I embrace the philosophy of keeping athletes in action, and exhausting conservative measures in order to keep them on the field.



Medical School

  • Barry University of Podiatric Medicine , 1997 , Miami , FL


  • Palmetto General Hospital , 1999 , Hialeah , FL


  • Palmetto General Hospital , 1999 , Hialeah , FL


  • Hadassah Medical Center , 2000 , Jerusalem , Israel

Philosophy of Care

I am a sports enthusiast who enjoys running and tennis in my free time. Despite being raised in Florida, I have taken up skiing and cheering on the Patriots now that I am a New Englander. I embrace the philosophy of keeping athletes in action, and exhausting conservative measures in order to keep them on the field. However, I also understand the need for surgical intervention in specific situations after careful consideration of the alternatives.


Dr. Thanh Dinh received her medical degree from Barry University School of Podiatric Medicine in Miami, and completed a residency in podiatric surgery at Palmetto General Hospital in Hialeah, Florida. She completed a fellowship in podiatric surgery at Hadassah Hebrew University Medical Center in Israel. Board certified in foot and ankle surgery, Dr. Dinh's clinical interests include hallux valgus deformities in adults and adolescents, reconstructive foot surgery, and sports medicine. Dr. Dinh is Assistant Professor of Surgery at Harvard Medical School and Director of Residency Education at BIDMC.


Publications powered by Harvard Catalyst Profiles

  1. Amnion Applications in the Foot and Ankle. Clin Podiatr Med Surg. 2019 Oct; 36(4):563-576. View abstract
  2. Growth factors in wound healing: the present and the future? Clin Podiatr Med Surg. 2015 Jan; 32(1):109-19. View abstract
  3. Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers. PLoS One. 2013; 8(12):e83314. View abstract
  4. Emerging drugs for the treatment of diabetic ulcers. Expert Opin Emerg Drugs. 2013 Jun; 18(2):207-17. View abstract
  5. Aliskiren improves vascular smooth muscle function in the skin microcirculation of type 2 diabetic patients with normal renal function. J Renin Angiotensin Aldosterone Syst. 2015 Jun; 16(2):344-52. View abstract
  6. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. J Vasc Surg. 2013 Apr; 57(4):997-1005. View abstract
  7. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012 Nov; 61(11):2937-47. View abstract
  8. The use of split-thickness skin grafts on diabetic foot ulcerations: a literature review. Plast Surg Int. 2012; 2012:715273. View abstract
  9. Treating diabetic ulcers. Expert Opin Pharmacother. 2011 Mar; 12(4):593-606. View abstract
  10. Current techniques to detect foot infection in the diabetic patient. Int J Low Extrem Wounds. 2010 Mar; 9(1):24-30. View abstract
  11. Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy. Diabetes Care. 2009 Aug; 32(8):1521-4. View abstract
  12. Peripheral arterial disease and diabetes: a clinical update. Int J Low Extrem Wounds. 2009 Jun; 8(2):75-81. View abstract
  13. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab. 2009 Jun; 94(6):2157-63. View abstract
  14. Evidence-based medicine and the management of the chronic wound: is it enough? Int J Low Extrem Wounds. 2008 Sep; 7(3):118-9. View abstract
  15. A retrospective assessment of partial calcanectomies and factors influencing postoperative course. J Foot Ankle Surg. 2007 Jul-Aug; 46(4):248-55. View abstract
  16. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care. 2007 Apr; 30(4):903-10. View abstract
  17. Treatment of diabetic ulcers. Dermatol Ther. 2006 Nov-Dec; 19(6):348-55. View abstract
  18. Microvascular changes in the diabetic foot. Int J Low Extrem Wounds. 2006 Sep; 5(3):149-59. View abstract
  19. Management and treatment of the diabetic foot. Orthopedics. 2006 07; 29(7):587-9. View abstract
  20. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg. 2006 Jun; 117(7 Suppl):152S-157S; discussion 158S-159S. View abstract
  21. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet. 2005 Nov 12; 366(9498):1711-7. View abstract
  22. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds. 2005 Sep; 4(3):154-9. View abstract
  23. Foot small muscle atrophy is present before the detection of clinical neuropathy. Diabetes Care. 2005 Jun; 28(6):1425-30. View abstract
  24. Microcirculation of the diabetic foot. Curr Pharm Des. 2005; 11(18):2301-9. View abstract
  25. Microcirculation in the diabetic foot: an update. Int J Low Extrem Wounds. 2004 Jun; 3(2):60-1. View abstract